Collectively, these findings reinforce existing evidence that GLP-1 receptor agonists serve as promising candidates for treating AUD (Fink-Jensen and Vilsbll 2016
If my math is right, their starting dose is 10-25 times higher than the dose (0.1/.25mg-2.5mg) that doctors have starting their notoriously sensitive patients on
Your healthcare provider will have to inform Cigna that you have performed behavioral modifications (e.g., increasing exercise) and a reduced-calorie diet for at least three months, and have either: A BMI of 30 or higher, or A BMI of 27 or higher, plus a weight-related comorbidity approved by Cigna, such as hypertension, Type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, or cardiovascular disease Wegovy is also FDA approved for cardiovascular risk reduction
Because lipotropic injections can vary by formulation, its important to review the ingredients, dosing schedule, and intended use with a licensed healthcare provider to determine which formula best fits your needs